Ong L, Chee N, Loh A
Eur J Clin Pharmacol. 2024; 80(10):1435-1444.
PMID: 38916726
DOI: 10.1007/s00228-024-03714-5.
Monson E, Shastri S, Chen D, Madden S, Keeshin B
Front Psychiatry. 2023; 14:1271165.
PMID: 38025462
PMC: 10654962.
DOI: 10.3389/fpsyt.2023.1271165.
Correll C, Fusar-Poli P, Leucht S, Karow A, Maric N, Moreno C
Neuropsychiatr Dis Treat. 2022; 18:201-219.
PMID: 35177905
PMC: 8843859.
DOI: 10.2147/NDT.S345066.
Jeon S, Park S, Kwon S, Kwon J
Front Psychiatry. 2021; 12:668704.
PMID: 34122182
PMC: 8187563.
DOI: 10.3389/fpsyt.2021.668704.
Jazi S, Ben-Amor L, Abadie P, Menard M, Choquette R, Berthiaume C
Can J Psychiatry. 2020; 66(7):645-656.
PMID: 33243011
PMC: 8243171.
DOI: 10.1177/0706743720974847.
Schizophrenia.
Hasan A, Falkai P, Lehmann I, Gaebel W
Dtsch Arztebl Int. 2020; 117(24):412-419.
PMID: 32865492
PMC: 7477695.
DOI: 10.3238/arztebl.2020.0412.
Risk factors and pattern of weight gain in youths using antipsychotic drugs.
van der Esch C, Kloosterboer S, van der Ende J, Reichart C, Kouijzer M, de Kroon M
Eur Child Adolesc Psychiatry. 2020; 30(8):1263-1271.
PMID: 32839872
PMC: 8310848.
DOI: 10.1007/s00787-020-01614-4.
Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects.
Solmi M, Fornaro M, Ostinelli E, Zangani C, Croatto G, Monaco F
World Psychiatry. 2020; 19(2):214-232.
PMID: 32394557
PMC: 7215080.
DOI: 10.1002/wps.20765.
Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial.
Correll C, Sikich L, Reeves G, Johnson J, Keeton C, Spanos M
World Psychiatry. 2020; 19(1):69-80.
PMID: 31922663
PMC: 6953545.
DOI: 10.1002/wps.20714.
Brexpiprazole has a low risk of dopamine D receptor sensitization and inhibits rebound phenomena related to D and serotonin 5-HT receptors in rats.
Amada N, Akazawa H, Ohgi Y, Maeda K, Sugino H, Kurahashi N
Neuropsychopharmacol Rep. 2019; 39(4):279-288.
PMID: 31487433
PMC: 7292306.
DOI: 10.1002/npr2.12076.
Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
Sultan R, Wang S, Crystal S, Olfson M
JAMA Netw Open. 2019; 2(7):e197850.
PMID: 31348506
PMC: 6661708.
DOI: 10.1001/jamanetworkopen.2019.7850.
Association of Antipsychotic Treatment With Risk of Unexpected Death Among Children and Youths.
Ray W, Stein C, Murray K, Fuchs D, Patrick S, Daugherty J
JAMA Psychiatry. 2018; 76(2):162-171.
PMID: 30540347
PMC: 6440238.
DOI: 10.1001/jamapsychiatry.2018.3421.
.
Lambert C, Panagiotopoulos C, Davidson J, Goldman R
Can Fam Physician. 2018; 64(9):663-666.
PMID: 30209097
PMC: 6135139.
Second-generation antipsychotics in children: Risks and monitoring needs.
Lambert C, Panagiotopoulos C, Davidson J, Goldman R
Can Fam Physician. 2018; 64(9):660-662.
PMID: 30209096
PMC: 6135131.
Dilemmas in the treatment of early-onset first-episode psychosis.
Hayes D, Kyriakopoulos M
Ther Adv Psychopharmacol. 2018; 8(8):231-239.
PMID: 30065814
PMC: 6058451.
DOI: 10.1177/2045125318765725.
Metabolic monitoring in children 5 years of age and younger prescribed second-generation antipsychotic medications.
Kauffman Y, Delate T, Botts S
Ment Health Clin. 2018; 7(1):1-6.
PMID: 29955489
PMC: 6007660.
DOI: 10.9740/mhc.2017.01.001.
Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis.
Balijepalli C, Druyts E, Zoratti M, Wu P, Kanji S, Rabheru K
Schizophr Res Treatment. 2018; 2018:1543034.
PMID: 29805808
PMC: 5899856.
DOI: 10.1155/2018/1543034.
A multi-national comparison of antipsychotic drug use in children and adolescents, 2005-2012.
Kalverdijk L, Bachmann C, Aagaard L, Burcu M, Glaeske G, Hoffmann F
Child Adolesc Psychiatry Ment Health. 2017; 11:55.
PMID: 29046716
PMC: 5637352.
DOI: 10.1186/s13034-017-0192-1.
Sex differences in aripiprazole sensitization from adolescence to adulthood.
Freeman E, Lin J, Chow S, Davis C, Li M
Pharmacol Biochem Behav. 2017; 156:39-47.
PMID: 28389140
PMC: 5716957.
DOI: 10.1016/j.pbb.2017.04.001.
Examining psychotropic medication use among youth in the U.S. by race/ethnicity and psychological impairment.
Le Cook B, Carson N, Kafali E, Valentine A, Rueda J, Coe-Odess S
Gen Hosp Psychiatry. 2017; 45:32-39.
PMID: 28274336
PMC: 7598773.
DOI: 10.1016/j.genhosppsych.2016.12.004.
